Neurophysiology of Cough Reflex Hypersensitivity
NOTCH
Pilot Study Investigating Central Sensitisation of the Cough Reflex in Subjects With Chronic Cough and Healthy Volunteers
1 other identifier
interventional
27
1 country
1
Brief Summary
Central sensitisation is an increase in the excitability of nerves within the central nervous system, which can lead to heightened sensitivity to certain stimuli. This process is involved in some chronic pain conditions e.g. migraines and non-cardiac chest pain. Recent work by our group suggests central sensitisation may be an important mechanism leading to chronic cough. The main questions in this study include:
- 1.Can the investigators induce temporary central sensitisation of the cough reflex in healthy volunteers for testing of new medications?
- 2.Can the investigators demonstrate exaggerated sensitisation in patients with chronic cough (indicating these patients are already centrally sensitised)?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 14, 2009
CompletedFirst Posted
Study publicly available on registry
September 15, 2009
CompletedStudy Start
First participant enrolled
March 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2013
CompletedJune 19, 2013
June 1, 2013
2.5 years
September 14, 2009
June 17, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Effect of oesophageal acid infusion on cough reflex sensitivity in chronic cough patients compared to healthy controls.
Outcome measures include; cough reflex sensitivity, pain threshold measures, 24 hour objective cough rate
baseline, immediatley after infusion, 90 minutes post infusion, 180 minutes post infusion, 24 hours after baseline
Study Arms (2)
Hydrochloric acid infusion
ACTIVE COMPARATORSaline
PLACEBO COMPARATORInterventions
Hydrochloric acid (0.15 molar) will be infused in to the lower oesophagus through a distal infusion port located at the tip of an oesophageal stimulation catheter.
Normal saline will be infused in to the lower oesophagus through a distal infusion port located at the tip of an oesophageal stimulation catheter.
Eligibility Criteria
You may qualify if:
- Over 18 years
- Measurable cough reflex sensitivity - required as is the primary end-point
- No current or past history of chronic cough or chronic respiratory disease
- Over 18 years
- Chronic persistent cough (\> 8 weeks) despite investigation and/or treatment trials for cough variant asthma/post-nasal drip and gastro-oesophageal reflux
- Normal chest radiograph - primary respiratory cause for cough excluded
- Normal lung function - primary respiratory cause for cough excluded Measurable cough reflex sensitivity - required as primary end-point
You may not qualify if:
- Recent upper respiratory tract infection (\<4 weeks) - this can lead to increased sensitivity of the cough reflex which resolves as the infection settles
- Pregnancy/breast-feeding - unknown effects of oesophageal acid infusion
- Current smokers or ex-smokers with \< 6 month abstinence or history \> 20 pack years - smoking can alter the sensitivity of the cough reflex
- Opiate or ACE inhibitor use or centrally acting medication - can alter the cough reflex sensitivity
- Symptomatic gastro-oesophageal reflux, post-nasal drip or asthma (chronic cough cohort may have been treated for these in the past but cough did not resolve) - these conditions are known to cause cough and alter cough reflex sensitivity
- Significant ongoing chronic respiratory/cardiovascular/gastro-intestinal/haematological/ neurological/psychiatric illness. We are aiming to recruit healthy volunteers and chronic cough patients who are otherwise healthy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Manchesterlead
- JP Moulton Charitable Foundationcollaborator
- Medical Research Councilcollaborator
Study Sites (1)
University Hospital of South Manchester
Manchester, M23 9LT, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ashley Woodcock, Prof
The University of Manchester
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MRC Clinician Scientist/Honorary Respiratory Consultant
Study Record Dates
First Submitted
September 14, 2009
First Posted
September 15, 2009
Study Start
March 1, 2010
Primary Completion
September 1, 2012
Study Completion
February 1, 2013
Last Updated
June 19, 2013
Record last verified: 2013-06